Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 96

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations

Ciurea, Stefan O., Chilkulwar, Abhishek, Saliba, Rima M., Chen, Julianne, Rondon, Gabriela, Patel, Keyur P., Khogeer, Haitham, Shah, Abdul R., Randolph, Brion V., Perez, Jorge M. Ramos, Popat, Uday, Hosing, Chitra M., Bashir, Qaiser, Mehta, Rohtesh, Al-Atrash, Gheath, Im, Jin, Khouri, Issa F., Kebriaei, Partow, Champlin, Richard E.·2018·Blood
DOI 10.1182/blood-2018-02-832360
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2018-02-832360

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 15

  1. Schlenk, 2010, Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A, J Clin Oncol, 28, 4642, 10.1200/JCO.2010.28.6856 · DOI · Paper page
  2. Baron, 2012, Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation, Leukemia, 26, 2462, 10.1038/leu.2012.135 · doi:10.1038/leu.2012.135
  3. Poiré, 2017, Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT), J Hematol Oncol, 10, 20, 10.1186/s13045-017-0393-3 · DOI
  4. Middeke, 2014, Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation, Blood, 123, 2960, 10.1182/blood-2013-12-544957 · DOI
  5. Fenaux, 1992, Mutations of the P53 gene in acute myeloid leukaemia, Br J Haematol, 80, 178, 10.1111/j.1365-2141.1992.tb08897.x · DOI
  6. Zhang, 2017, The role of p53 in myelodysplastic syndromes and acute myeloid leukemia: molecular aspects and clinical implications, Leuk Lymphoma, 58, 1777, 10.1080/10428194.2016.1266625 · DOI
  7. Aldoss, 2017, Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status, Haematologica, 102, 2030, 10.3324/haematol.2017.172544 · DOI
  8. Seifert, 2009, The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia, Leukemia, 23, 656, 10.1038/leu.2008.375 · DOI · Paper page
  9. Bowen, 2009, TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis, Leukemia, 23, 203, 10.1038/leu.2008.173 · DOI · Paper page
  10. Grossmann, 2012, A novel hierarchical prognostic model of AML solely based on molecular mutations, Blood, 120, 2963, 10.1182/blood-2012-03-419622 · DOI · Paper page
  11. Kim, 2015, Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation, Bone Marrow Transplant, 50, 1132, 10.1038/bmt.2015.110 · DOI
  12. Della Porta, Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation [published online ahead of print 6 September 2016]
  13. Middeke, 2012, Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-, Blood, 120, 2521, 10.1182/blood-2012-03-417972 · DOI
  14. Kadia, TP53 mutations in newly diagnosed acute myeloid leukemia: clinicomolecular characteristics, response to therapy, and outcomes [published online ahead of print 26 July 2016]
  15. Ciurea, 2017, Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation, Blood, 130, 1857, 10.1182/blood-2017-05-785659 · DOI · Paper page

Cited by

See all 96

Metadata

Authors
Ciurea, S. O., Chilkulwar, A., Saliba, R. M., Chen, J., Rondon, G., Patel, K. P., Khogeer, H., Shah, A. R., Randolph, B. V., Perez, J. M. R., Popat, U., Hosing, C. M., Bashir, Q., Mehta, R., Al-Atrash, G., Im, J., Khouri, I. F., Kebriaei, P., & Champlin, R. E.
Affiliations
  • Department of Stem Cell Transplantation and Cellular Therapy and
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
Venue
Blood
Publisher
American Society of Hematology
Published
2018-06-28
Volume
131
Issue
26
Pages
2989-2992
ISSN
  • 0006-4971
  • 1528-0020
DOI
10.1182/blood-2018-02-832360
Cited by
96
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations. https://app.cochat.ai/papers/10.1182/blood-2018-02-832360
The paper
Ciurea, S. O., Chilkulwar, A., Saliba, R. M., Chen, J., Rondon, G., Patel, K. P., Khogeer, H., Shah, A. R., Randolph, B. V., Perez, J. M. R., Popat, U., Hosing, C. M., Bashir, Q., Mehta, R., Al-Atrash, G., Im, J., Khouri, I. F., Kebriaei, P., & Champlin, R. E. (2018). Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients with TP53 mutations. Blood. https://doi.org/10.1182/blood-2018-02-832360

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.